Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03624478 · ClinicalTrials.gov registry record · Phase 2
Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT03624478: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT03624478 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03624478, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
This phase II trial studies how well hypofractionated radiation therapy works in treating participants with breast cancer before surgery. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.
Interventions
- RADIATION Hypofractionated Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-11-20 |
| Est. Completion | 2025-09-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03624478
The ClinicalTrials.gov registry entry for NCT03624478 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hypofractionated Radiation Therapy is the first listed.
NCT03624478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03624478 about?
NCT03624478 is a clinical study titled "Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery". This phase II trial studies how well hypofractionated radiation therapy works in treating participants with breast cancer before surgery. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effe...
What is the current status of trial NCT03624478?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2018-11-20. Estimated completion is 2025-09-24.
What interventions are being tested in trial NCT03624478?
The interventions under investigation include: Hypofractionated Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT03624478?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.